Patent details

Basic Information

Publication number:

EP3440086

PCT Application Number:

IB2017051739

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP177152808

PCT Publication Number:

WO2017175091

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

CRYSTALLINE FORMS OF LORLATINIB MALEATE

French Title of Invention:

FORMES CRISTALLINES DE MALÉATE DE LORLATINIB

German Title of Invention:

KRISTALLINE FORMEN VON LORLATINIB-MALEAT

SPC Number:

Dates

Filing date:

27/03/2017

Grant date:

12/08/2020

EP Publication Date:

13/02/2019

PCT Publication Date:

12/10/2017

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

12/08/2020

EP B1 Publication Date:

12/08/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

27/03/2021

Expiration date:

27/03/2037

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

05/08/2020

 

 

Name:

Pfizer Inc.

Address:

235 East 42nd Street, New York, NY 10017, United States (US)

Inventor

Name:

PENCHEVA, Klimentina Dimitrova

Address:

United Kingdom (GB)

Priority

Priority Number:

201662320305 P

Priority Date:

08/04/2016

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/439; C07D 498/18;

Publication

European Patent Bulletin

1

Issue number:

202033

Publication date:

12/08/2020

Description:

Grant (B1)

2

Issue number:

202038

Publication date:

16/09/2020

Description:

Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages